Product Catalog

KPVSpecifications & Batch COA

Alpha-MSH-derived tripeptide with potent anti-inflammatory and gut-healing properties. Used in IBD research.

KERUIHK-0304KPV product vial
Lyophilized PowderProduct image
Repair & Anti-Inflammatory

KPV

ResearchKERUIHK-0304

Alpha-MSH-derived tripeptide with potent anti-inflammatory and gut-healing properties. Used in IBD research.

Product Specifications

CAS Number
13147-13-2
Catalog Purity
≥99.02%
Form
Lyophilized Powder
Catalog Grade
Research
View batch documentation

Product Details

KPV specifications

Use the product name, catalog reference and available specifications below when discussing your requirements with our team.

Product
KPV
Catalog reference
KERUIHK-0304
CAS number
13147-13-2
Category
Repair & Anti-Inflammatory
Physical form
Lyophilized Powder

Latest reported batch: KPV

Batch PB-2026-KPV-7030 · Oct 12, 2026

Reported appearance
White powder
Reported molecular weight / identity
382.42 Da
Analytical method
RP-HPLC / ESI-MS

Reported analytical results

HPLC Purity
99.70%Report specification: ≥99.0%
Molecular Weight (MS)
382.42 DaReport specification: 382.5 ± 0.2 Da
Amino Acid Analysis
ConformsReport specification: Conforms to sequence
Appearance
White powderReport specification: White to off-white powder
Show 4 more test results
Solubility
Soluble in waterReport specification: Soluble in water (≥10 mg/mL)
Water Content (KF)
4.44%Report specification: ≤ 6.0%
Residual Solvents
< ICH Q3C limitsReport specification: ICH Q3C Class 2
Sterility (USP <71>)
No growth observedReport specification: No evidence of microbial growth
Source COA: PB-2026-KPV-7030-R20261012
Explore this category

Batch Documentation

Certificates of Analysis

Open a batch below to view its full report in our COA library, including available analytical attachments and PDF download.

PB-2026-KPV-7030Report product: KPVOct 12, 2026 · Reported purity: 99.70%View this batch COA
PB-2026-KPV-7030Report product: KPVAug 28, 2026 · Reported purity: 99.5%View this batch COA
PB-2026-KPV-0192Report product: KPVJul 18, 2026 · Reported purity: 99.0%View this batch COA
Show 1 earlier reports
PB-2026-KPV-0059Report product: KPVApr 27, 2026 · Reported purity: 99.2%View this batch COA

Product Inquiry

Request a KPV quotation

We synthesize any sequence at any scale — from milligram research quantities to multi-kilogram commercial batches. OEM, private label, and GMP manufacturing available. Response within 24 hours.

Discuss your requirements
Back to all products